Author

Y. A. Guo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Jacobsen Skanderup· 2 shared M. M. Chang· 2 shared A. L. K. Tan· 1 shared A. Tan· 1 shared C. G. Anene-Nzelu· 1 shared C. Xu· 1 shared D. Tan· 1 shared E. Revkov· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Jacobsen Skanderup

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A transcriptome-wide meta-analysis reveals lack of cancer-cell intrinsic determinants of response to immune checkpoint blockade

Y. A. Guo, T. Kulshrestha, M. M. Chang, I. Kassam, E. Revkov, S. Rizzetto, A. Tan, D. Tan, I. B. Tan, A. Jacobsen Skanderup

This study performs a transcriptome-wide meta-analysis to identify determinants of immune checkpoint blockade response, finding that stromal factors, not cancer-cell intrinsic features, are key predictors across tumor types.

bioRxiv · Jul 30, 2023 · PreprintCancer Biology

Integrative Epigenomic and High-Throughput Functional Enhancer Profiling Reveals Determinants of Enhancer Heterogeneity in Gastric Cancer

T. Sheng, S. W. T. Ho, W. F. Ooi, C. Xu, M. Xing, N. Padmanabhan, K. K. Huang, L. Ma, M. Ray, Y. A. Guo, S. N. Leng, C. G. Anene-Nzelu, M. M. Chang, M. Razavi-Mohseni, M. Beer, , P. Tan

The paper identifies enhancer heterogeneity in gastric cancer by integrating epigenomic data and functional assays, linking it to genetic and regulatory factors.

bioRxiv · Jun 9, 2021Cancer Biology